At Stony Brook Drugs, a brand new VP

Stony Brook Drugs has appointed Todd Griffin as vp for medical providers and vice dean for medical affairs, efficient Jan. 1.

“I’m delighted Dr. Griffin is continuous to develop his profession with us and I look ahead to working with him to foster group relationships and construct a profitable future for Stony Brook Drugs,” Dr. Hal Paz govt vp for well being sciences at Stony Brook College and CEO of Stony Brook College Drugs, stated in a press release.

“Dr. Griffin’s intensive information of our group and medical experience makes him poised for fulfillment on this function,” he added.

Griffin may have accountability for medical management throughout Stony Brook Drugs and oversight of all ambulatory services. He may even present oversight to the Clinically Built-in Community throughout Stony Brook Drugs college and Stony Brook Group Drugs physicians.

He’ll function the medical govt for all associates and partnering organizations and can develop plans for coordination of inpatient and outpatient care, selling operational effectivity within the inpatient surroundings and seamless transition to the outpatient setting. Griffin will work with Stony Brook Drugs management to develop and implement the imaginative and prescient and technique to develop and preserve the success of its medical enterprise.

As a clinician, Griffin is a minimally invasive/robotic gynecologic surgeon who was instrumental in serving to Stony Brook begin a robotics program. As an educator, he has served as a clerkship director, residency program director and vice chair for schooling. In 2009, he was chosen to function the chief medical officer  of Stony Brook College Hospital. On this function, he was accountable for enhancing affected person security, high quality and operational effectivity of the medical providers.

As chief medical officer, he was a part of the workforce that developed the plan to ascertain a well being system via the acquisition of different hospitals and doctor practices. In 2012, he was recruited to turn into chair for OB/GYN to develop a strategic plan for rising the footprint of ladies’s well being. He served each as chair of OB/GYN and chief medical officer till 2014.

As chair, Griffin has had a variety of vital accomplishments. He has grown the overall income of the division from $12 million in 2012 to just about $100 million anticipated in 2022. He expanded the school from 22 to greater than 70 full-time college and developed three outpatient medical websites. The analysis mission of the division has additionally grown considerably as demonstrated by complete NIH funding, publications and scholarly output.

From 2018 to 2021, Griffin served because the Stony Brook College Hospital Medical Board president. In 2021, he was elected to function chair of Scientific Observe Administration Plan. In 2022, he acquired the Chancellor’s Award for Excellence in School Service.

When Griffin assumes his new function in 2023, he’ll step down as chair of the Division of Obstetrics, Gynecology and Reproductive Drugs. An interim chair of the division might be appointed within the close to future.